Covered recipient · General Payments record
TESSA M RAWSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$4,336.17
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,346.28 | 109 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $439.19 | 34 |
| MDD US Operations, LLC | $394.97 | 1 |
| UCB, Inc. | $223.43 | 9 |
| Neurelis, Inc. | $162.87 | 9 |
| PFIZER INC. | $162.00 | 13 |
| Teva Pharmaceuticals USA, Inc. | $102.93 | 4 |
| EMD Serono, Inc. | $83.28 | 3 |
| ACADIA Pharmaceuticals Inc | $79.85 | 3 |
| Grifols USA, LLC | $61.32 | 3 |
| Genentech USA, Inc. | $52.81 | 2 |
| ARGENX US, INC. | $52.56 | 2 |
| Lilly USA, LLC | $52.42 | 3 |
| TG THERAPEUTICS, INC. | $51.97 | 2 |
| SK Life Science, Inc. | $47.42 | 2 |
| EISAI INC. | $44.77 | 2 |
| Octapharma USA, Inc. | $43.79 | 2 |
| Otsuka America Pharmaceutical, Inc. | $40.93 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.88 | 2 |
| Lundbeck LLC | $40.86 | 2 |
| Biogen, Inc. | $40.42 | 2 |
| Alnylam Pharmaceuticals Inc. | $34.33 | 2 |
| Acerta Pharma LLC | $32.98 | 2 |
| CSL Behring | $30.88 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.80 | 1 |
| Vanda Pharmaceuticals Inc. | $13.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (109)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.